Brief: Protara Therapeutics Q2 EPS USD -0.45
06/08/2024 13:00
Aug 06 (Reuters) - Protara Therapeutics Q2 operating expenses USD 10.661 million. * Q2 net income USD -9.513 million * Q2 income from operations USD -10.661 million
Recent news on Protara Therapeutics
See all newsProtara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Protara Therapeutics Q2 net loss widens on higher expenses
Brief: Protara Therapeutics - Enters Sales Agreement With TD Cowen For Common Stock Offering
Brief: Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses
Protara Therapeutics Q1 net loss widens on higher expenses